The AlzChem Group has a new shareholder. Both parties, Evonik Degussa GmbH and the Luxembourg-based investment company bluO, yesterday signed the agreement that has been in preparation for a long time.
AlzChem Holding, with the operating companies AlzChem Hart, AlzChem Trostberg and Nigu, and with a new management and organization, began business In October 2006, and after a successful realignment of the company the sales process began in spring 2008. Self-assured, ambitious and motivated, AlzChem intends to further develop the businesses in future and continue writing its success stories.
Amidst the economic crisis, AlzChem has been able to maintain its position well in 2008 and during the current fiscal year. The results of the past three years show a clear upswing and have confirmed the business strategy of being broadly positioned and thus able to serve many attractive segments of the domestic and international industry.
AlzChem’s product range is based primarily on NCN chemistry – molecules with the typical nitrogen-carbon-nitrogen compound. The most import applications for the Bavarian products are found in agriculture, e.g. plant protection, growth regulation and multipurpose fertilizers, in chemicals, e. g. for medicines and ingredients for cosmetics and dietary supplements, pigments for dyes, pharmaceutical ingredients and synthetic components and propellants for airbags.
AlzChem intends to continue to expand its market positions. Promising projects and innovations underlining this purpose are already in preparation, and the next development stage can now be moved to the decision stage with the new owner.
The successful history and tradition of the chemical industry located by the river Alz is continuing. AlzChem has the opportunity to venture a new beginning under new ownership – with proven expertise, professional employees, innovational strength and courage together with recognized and reliable partners and customers. It will continue to expand its position as an established presence in the region and on the international stage.
Ulli Seibel, the bluO manager, will be adding his strengths to the management of the company, and together with the present managing director Stefan Greger will be driving the development of AlzChem forward. Michael Hoffmann, appointed managing director of AlzChem just in September 2009, is leaving the company and returning to the previous shareholder Evonik.
Further Information
Contact
Nicol Schindlbeck
----------------------------
Head of Communications
T +49 8621 86-2460
F +49 8621 86-2020
Top